Valuation: Olympus Corporation

Market Cap 2,131B 13.68B 11.91B 11.27B 10.24B 19.14B 1,310B 19.23B 134B 51.92B 666B 51.38B 50.23B P/E 2027 *
20.5x
P/E 2028 * 17.7x
Enterprise Value 2,213B 14.2B 12.37B 11.71B 10.64B 19.87B 1,360B 19.97B 139B 53.92B 691B 53.35B 52.16B EV / Sales 2027 *
2.05x
EV / Sales 2028 * 1.96x
Free-Float
94.58%
Yield 2027 *
1.51%
Yield 2028 * 1.58%
1 day-2.01%
1 week-0.86%
Current month-3.72%
1 month-3.86%
3 months+23.08%
6 months+47.90%
Current year+0.16%
1 week 12.41
Extreme 12.41
13.01
1 month 12.19
Extreme 12.19
13.72
Current year 8.08
Extreme 8.08
13.72
1 year 8.08
Extreme 8.08
13.73
3 years 8.08
Extreme 8.08
19.69
5 years 8.08
Extreme 8.08
74.99
10 years 6.26
Extreme 6.2625
74.99
Manager TitleAgeSince
Chief Executive Officer 63 01/06/2025
Director of Finance/CFO 59 01/04/2026
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 69 01/04/2023
Director/Board Member 41 01/06/2019
Director/Board Member 63 01/06/2019
Change 5-day change 1-year change 3-year change Capi.($)
-2.01%-0.86% - - 13.81B
-0.33%+7.67%+36.48%+29.32% 243B
+0.93%+5.85%+8.49%-16.52% 149B
+1.06%+6.66%-9.66%+32.05% 135B
-0.32%+1.33%-55.67%-17.83% 63.11B
-0.09%+4.81%+18.61%+21.23% 50.87B
-1.04%-0.47%-19.59%-15.95% 49.1B
-0.31%+5.61%+21.59%+37.70% 44.08B
-0.78%+4.64%+39.46%+56.29% 42.22B
-1.66%+16.76%+133.96%+69.26% 37.02B
Average -0.44%+5.46%+19.30%+21.73% 90.52B
Weighted average by Cap. +0.00%+6.30%+15.82%+18.15%

Financials

2027 *2028 *
Net sales 1,080B 6.93B 6.04B 5.72B 5.19B 9.7B 664B 9.75B 68.08B 26.33B 337B 26.05B 25.47B 1,122B 7.2B 6.27B 5.94B 5.39B 10.07B 690B 10.12B 70.69B 27.34B 350B 27.05B 26.45B
Net income 105B 676M 589M 558M 507M 946M 64.78B 951M 6.64B 2.57B 32.92B 2.54B 2.48B 122B 786M 684M 648M 589M 1.1B 75.26B 1.1B 7.72B 2.98B 38.25B 2.95B 2.89B
Net Debt 81.71B 524M 457M 432M 393M 734M 50.23B 737M 5.15B 1.99B 25.53B 1.97B 1.93B 64.09B 411M 358M 339M 308M 576M 39.39B 578M 4.04B 1.56B 20.02B 1.55B 1.51B
Logo Olympus Corporation
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, scientific and other products. The Company operates through three business segments. The Endoscope segment provides gastrointestinal endoscopes, surgical endoscopes, and medical services. The Therapeutic Equipment segment provides gastrointestinal treatment instruments, urology products, respiratory products, energy devices, otolaryngology products and gynecology products. The Others segment provides biomaterials and orthopedic instruments. The Company is also engaged in the business activities, including holding companies and financial investments related to each business.
Employees
28,138
Date Price Change Volume
18/09/26 US$12.69 -2.01% 6,239
17/09/26 US$12.95 +2.45% 25,753
16/09/26 US$12.64 -0.16% 20,572
15/09/26 US$12.66 -1.17% 39,453
14/09/26 US$12.81 +0.08% 30,875
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
2,024.00JPY
Average target price
2,161.54JPY
Spread / Average Target
+6.80%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!